Fig. 2From: Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancerKaplan-Meier method showing 5-year breast cancer-specific survival curves of HER2-positive infiltrating ductal carcinoma of breast comparing patients of positive and negative stomatin staining. Significant reduction of proportion surviving was noted in patients of stomatin (−) (n = 32), compared with patients of stomatin (+) (n = 36). p = 0.005Back to article page